All In Biotech

Drug Trial Radar · NCT05855395

The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19

A Bidimensional Early Intervention Strategy of Standard of Care Combined With Host Immunomodulation in Elderly Patients With Mild or Moderate COVID-19: A Multicentre, Randomized, Controlled, Adaptive Platform Study

Last checked: Nov 19, 2026Latest source record: Jul 12, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 5,815 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

5,815

Planned (sponsor's estimate)

Start

May 26, 2023

Primary completion

May 1, 2024

Study completion Dec 1, 2024

Sponsor

Lead sponsor
Huashan HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 11, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is aimed to explore the dual-dimensional early intervention strategy of standard of care combined with host immunomodulation in elderly patients with mild and moderate COVID-19.

Conditions

  • COVID-19

Interventions

  • GlucocorticoidDrug

    standard of care combined with glucocorticoid(dexamethasone: 3mg qd x 5 days; or prednisone: 20mg qd x 5 days; or methylprednisolone: 16mg qd x 5 days)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of patients who progress to severe or critical COVID-19 within 28 daysTime frame: In 28 days

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Fujian Medical University

    Fuzhou, Fujian, China · Not yet recruiting

  • Quanzhou First Hospital

    Quanzhou, Fujian, China · Not yet recruiting

  • The Fifth Affiliated Hospital of Sun Yat-sen University

    Guangzhou, Guangdong, China · Recruiting

  • Attached Hospital of Zunyi Medical College

    Zunyi, Guizhou, China · Not yet recruiting

  • Huaihua First People's Hospital

    Huaihua, Hunan, China · Recruiting

  • Nanjing Hospital of Traditional Chinese Medicine

    Nanjing, Jiangsu, China · Recruiting

  • Affiliated Drum Tower Hospital, Medical School of Nanjing University

    Nanjing, Jiangsu, China · Not yet recruiting

  • Wuxi Fifth People's Hospital

    Wuxi, Jiangsu, China · Recruiting

  • The People's Hospital Of Xingguo County

    Ganzhou, Jiangxi, China · Not yet recruiting

  • The First Hospital of Shanxi Medical University

    Taiyuan, Shanxi, China · Recruiting

  • Affiliated Hospital of Southwest Medical University

    Luzhou, Sichuan, China · Not yet recruiting

  • The First People's Hospital Of YunNan

    Kunming, Yunnan, China · Recruiting

  • People's Hospital of Qiubei County, Yunnan Province

    Wenshan, Yunnan, China · Recruiting

  • Hangzhou Linping District First People's Hospital

    Hanzhou, Zhejiang, China · Not yet recruiting

  • Wenzhou Central Hospital

    Wenzhou, Zhejiang, China · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.